FB Pixel no scriptMedtech | KrASIA Archives
MENU
KrASIA

Medtech

News

Immunai raises USD 215 million for its drug discovery platform

Immunai uses analytics and machine learning to improve the efficiency of immunotherapies, revealing insights that lead to the development of new therapy programs.

3 mins read
  • This is the first known collaboration between an Israeli company and a Japanese pharmaceutical company to bring AI to clinical drug development.

    News

    Israel’s CytoReason launches AI drug discovery platform in Japanese market

    4 mins read

Most Recent

See All